The center will join Amgen's global Research and Development network, which consists of seven research laboratories, further expanding the company's research and scientific capabilities. The new site reflects Amgen's continued focus on fighting the world's toughest diseases by harnessing the best of biology and technology. By integrating advanced scientific capabilities with data and digital innovation, the company aims to accelerate the discovery and development of innovative medicines for patients worldwide.

The center is expected to be operational in 2027, and will bring together scientists and technologists across discovery chemistry, drug metabolism & pharmacokinetics and precision medicine, working closely with Amgen's research sites around the world. This approach is designed to enhance how medicines are discovered and developed, improving speed, precision, and efficiency.

Genome Valley offers strong scientific expertise and infrastructure, and the new facility will complement Amgen's existing technology and innovation site in Hyderabad. Together, these sites will enable closer integration of wet-laboratory science with innovative technology, advancing how the company develops medicines.